These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6307803)

  • 1. Quantitative determination of non-sulfated bile acids in the serum of patients with hepatobiliary diseases by mass fragmentography.
    Takikawa H; Beppu T; Seyama Y; Wada T
    Gastroenterol Jpn; 1983 Jun; 18(3):246-51. PubMed ID: 6307803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum concentrations of bile acid glucuronides in hepatobiliary diseases.
    Takikawa H; Otsuka H; Beppu T; Seyama Y; Yamakawa T
    Digestion; 1983; 27(4):189-95. PubMed ID: 6653918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative determination of individual non-sulfated bile acids and sulfated lithocholic acid in serum by mass fragmentography.
    Beppu T; Seyama Y; Kasama T; Yamakawa T
    J Biochem; 1981 Jun; 89(6):1963-73. PubMed ID: 7287668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of sulfated and nonsulfated bile acids in serum by mass fragmentography.
    Murata N; Beppu T; Takikawa H; Otsuka H; Kasama T; Seyama Y
    Steroids; 1983 Nov; 42(5):575-92. PubMed ID: 6101264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative determination of bile acid glucuronides in serum by mass fragmentography.
    Takikawa H; Otsuka H; Beppu T; Seyama Y; Yamakawa T
    J Biochem; 1982 Oct; 92(4):985-98. PubMed ID: 7174649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfated and nonsulfated bile acids in urine, serum, and bile of patients with hepatobiliary diseases.
    Makino I; Hashimoto H; Shinozaki K; Yoshino K; Nakagawa S
    Gastroenterology; 1975 Mar; 68(3):545-53. PubMed ID: 1112456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bile acids in the serum of patients with extrahepatic cholestasis with chronic liver diseases].
    Erb W; Schreiber J; Walczak M
    Z Gastroenterol; 1973 May; 11(4):279-88. PubMed ID: 4803425
    [No Abstract]   [Full Text] [Related]  

  • 8. Determination of 3 beta-hydroxy-5-cholenoic acid in serum of hepatobiliary diseases--its glucuronidated and sulfated conjugates.
    Takikawa H; Otsuka H; Beppu T; Seyama Y
    Biochem Med; 1985 Jun; 33(3):393-400. PubMed ID: 4015637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum bile acids in liver disease.
    Neale G; Lewis B; Weaver V; Panveliwalla D
    Gut; 1971 Feb; 12(2):145-52. PubMed ID: 5548561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of serum levels of tryptophan in hepatobiliary disease.
    Yoshida K; Hirayama C
    Clin Chim Acta; 1980 Feb; 101(2-3):235-40. PubMed ID: 6244122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary concentrations of bile acid glucuronides and sulfates in hepatobiliary diseases.
    Takikawa H; Beppu T; Seyama Y
    Gastroenterol Jpn; 1984 Apr; 19(2):104-9. PubMed ID: 6735068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfated and nonsulfated bile acid in human serum.
    Makino I; Nakagawa S; Shinozaki K; Mashimo K
    Lipids; 1972 Nov; 7(11):750-2. PubMed ID: 4634551
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of plasma bile acid profiles in patients with liver diseases associated with cholestasis.
    Bremmelgaard A; Almé B
    Scand J Gastroenterol; 1980; 15(5):593-600. PubMed ID: 7444367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum bile acids in hepatobiliary disease].
    Esquivel López A; González Espinola G; Gutiérrez Nava R; García Arreola RM
    Rev Gastroenterol Mex; 1982; 47(1):9-12. PubMed ID: 7100761
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum bile acids in the diagnosis of hepatobiliary disease.
    Pennington CR; Ross PE; Bouchier IA
    Gut; 1977 Nov; 18(11):903-8. PubMed ID: 590851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of serum bile acid measurement in liver diseases.
    Morita T; Matsuyama Y; Fujimoto T; Higuchi M; Tsujii T; Matsuoka Y
    Gastroenterol Jpn; 1978; 13(6):491-502. PubMed ID: 748093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical examination of serum bile acids for the diagnosis of hepatobiliary diseases].
    Fujiwara K
    Rinsho Byori; 1989 Oct; 37(10):1114-21. PubMed ID: 2601071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress markers, secondary bile acids and sulfated bile acids classify the clinical liver injury type: Promising diagnostic biomarkers for cholestasis.
    Masubuchi N; Sugihara M; Sugita T; Amano K; Nakano M; Matsuura T
    Chem Biol Interact; 2016 Aug; 255():83-91. PubMed ID: 26325587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An evaluation of the determination of serum conjugated cholic acid in patients with hepatobiliary diseases].
    Fan SL; Li ZJ; Chen WY
    Zhonghua Nei Ke Za Zhi; 1982 Jul; 21(7):386-9. PubMed ID: 7172873
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma bile acid levels and liver disease.
    Magyar I; Loi HG; Fehér T
    Acta Med Acad Sci Hung; 1981; 38(2):109-15. PubMed ID: 7324802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.